vs
MONARCH CASINO & RESORT INC（MCRI）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
MONARCH CASINO & RESORT INC的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.8倍（$136.6M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 8.9%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 3.2%）
君主赌场度假村集团是美国知名博彩度假企业，旗下运营位于内华达州里诺的亚特兰蒂斯赌场度假水疗中心。该物业设有三座酒店塔楼，共824间客房及套房，博彩区面积达64814平方英尺，是里诺当地盈利水平领先、定位高端的度假目的地，累计已投入近1.5亿美元用于设施升级。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
MCRI vs PBYI — 直观对比
营收规模更大
MCRI
是对方的1.8倍
$75.5M
营收增速更快
PBYI
高出18.8%
8.9%
两年增速更快
PBYI
近两年复合增速
3.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $136.6M | $75.5M |
| 净利润 | $27.6M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 25.6% | 22.7% |
| 净利率 | 20.2% | — |
| 营收同比 | 8.9% | 27.7% |
| 净利润同比 | 38.9% | — |
| 每股收益（稀释后） | $1.52 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MCRIPBYI
| Q1 26 | $136.6M | — | ||
| Q4 25 | $140.0M | $75.5M | ||
| Q3 25 | $142.8M | $54.5M | ||
| Q2 25 | $136.9M | $52.4M | ||
| Q1 25 | $125.4M | $46.0M | ||
| Q4 24 | $134.5M | $59.1M | ||
| Q3 24 | $137.9M | $80.5M | ||
| Q2 24 | $128.1M | $47.1M |
净利润MCRIPBYI
| Q1 26 | $27.6M | — | ||
| Q4 25 | $22.9M | — | ||
| Q3 25 | $31.6M | $8.8M | ||
| Q2 25 | $27.0M | $5.9M | ||
| Q1 25 | $19.9M | $3.0M | ||
| Q4 24 | $4.2M | — | ||
| Q3 24 | $27.6M | $20.3M | ||
| Q2 24 | $22.7M | $-4.5M |
毛利率MCRIPBYI
| Q1 26 | — | — | ||
| Q4 25 | 20.8% | 69.3% | ||
| Q3 25 | 26.7% | 77.7% | ||
| Q2 25 | 25.5% | 76.5% | ||
| Q1 25 | 20.2% | 77.1% | ||
| Q4 24 | 2.9% | 76.4% | ||
| Q3 24 | 25.6% | 63.9% | ||
| Q2 24 | 23.0% | 77.4% |
营业利润率MCRIPBYI
| Q1 26 | 25.6% | — | ||
| Q4 25 | 21.3% | 22.7% | ||
| Q3 25 | 27.1% | 17.6% | ||
| Q2 25 | 25.8% | 12.7% | ||
| Q1 25 | 20.4% | 8.7% | ||
| Q4 24 | 3.1% | 22.6% | ||
| Q3 24 | 25.5% | 27.4% | ||
| Q2 24 | 22.9% | -4.6% |
净利率MCRIPBYI
| Q1 26 | 20.2% | — | ||
| Q4 25 | 16.4% | — | ||
| Q3 25 | 22.1% | 16.2% | ||
| Q2 25 | 19.7% | 11.2% | ||
| Q1 25 | 15.8% | 6.5% | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 20.0% | 25.2% | ||
| Q2 24 | 17.7% | -9.6% |
每股收益（稀释后）MCRIPBYI
| Q1 26 | $1.52 | — | ||
| Q4 25 | $1.25 | $0.26 | ||
| Q3 25 | $1.69 | $0.17 | ||
| Q2 25 | $1.44 | $0.12 | ||
| Q1 25 | $1.05 | $0.06 | ||
| Q4 24 | $0.25 | $0.40 | ||
| Q3 24 | $1.47 | $0.41 | ||
| Q2 24 | $1.19 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $120.1M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $549.8M | $130.3M |
| 总资产 | $725.2M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资MCRIPBYI
| Q1 26 | $120.1M | — | ||
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M |
总债务MCRIPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
股东权益MCRIPBYI
| Q1 26 | $549.8M | — | ||
| Q4 25 | $537.7M | $130.3M | ||
| Q3 25 | $558.4M | $115.3M | ||
| Q2 25 | $539.2M | $104.7M | ||
| Q1 25 | $535.6M | $97.1M | ||
| Q4 24 | $517.7M | $92.1M | ||
| Q3 24 | $513.3M | $71.1M | ||
| Q2 24 | $498.4M | $48.5M |
总资产MCRIPBYI
| Q1 26 | $725.2M | — | ||
| Q4 25 | $712.8M | $216.3M | ||
| Q3 25 | $725.4M | $202.9M | ||
| Q2 25 | $705.8M | $194.9M | ||
| Q1 25 | $712.1M | $196.2M | ||
| Q4 24 | $691.6M | $213.3M | ||
| Q3 24 | $671.1M | $220.7M | ||
| Q2 24 | $672.4M | $205.0M |
负债/权益比MCRIPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流MCRIPBYI
| Q1 26 | — | — | ||
| Q4 25 | $38.1M | $14.4M | ||
| Q3 25 | $56.0M | $9.7M | ||
| Q2 25 | $34.1M | $14.1M | ||
| Q1 25 | $36.5M | $3.6M | ||
| Q4 24 | $37.8M | $15.6M | ||
| Q3 24 | $40.3M | $11.0M | ||
| Q2 24 | $24.3M | $1.0M |
自由现金流MCRIPBYI
| Q1 26 | — | — | ||
| Q4 25 | $32.2M | $14.4M | ||
| Q3 25 | $53.5M | $9.7M | ||
| Q2 25 | $26.0M | $14.1M | ||
| Q1 25 | $16.6M | $3.6M | ||
| Q4 24 | $26.2M | $15.6M | ||
| Q3 24 | $35.4M | $11.0M | ||
| Q2 24 | $11.0M | $1.0M |
自由现金流率MCRIPBYI
| Q1 26 | — | — | ||
| Q4 25 | 23.0% | 19.1% | ||
| Q3 25 | 37.5% | 17.7% | ||
| Q2 25 | 19.0% | 26.8% | ||
| Q1 25 | 13.3% | 7.7% | ||
| Q4 24 | 19.5% | 26.4% | ||
| Q3 24 | 25.7% | 13.7% | ||
| Q2 24 | 8.5% | 2.1% |
资本支出强度MCRIPBYI
| Q1 26 | — | — | ||
| Q4 25 | 4.2% | 0.0% | ||
| Q3 25 | 1.7% | 0.0% | ||
| Q2 25 | 5.9% | 0.0% | ||
| Q1 25 | 15.8% | 0.1% | ||
| Q4 24 | 8.6% | 0.0% | ||
| Q3 24 | 3.6% | 0.0% | ||
| Q2 24 | 10.4% | 0.0% |
现金转化率MCRIPBYI
| Q1 26 | — | — | ||
| Q4 25 | 1.66× | — | ||
| Q3 25 | 1.77× | 1.10× | ||
| Q2 25 | 1.26× | 2.41× | ||
| Q1 25 | 1.84× | 1.21× | ||
| Q4 24 | 8.98× | — | ||
| Q3 24 | 1.46× | 0.54× | ||
| Q2 24 | 1.07× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MCRI
| Casino | $79.7M | 58% |
| Food and beverage | $31.7M | 23% |
| Hotel | $19.0M | 14% |
| Other | $6.1M | 5% |
PBYI
暂无分部数据
